Stonepeak’s Infrastructure Debt Note Begins Trading on the ASX
Stonepeak-Plus INFRA1 Note has commenced trading on the ASX under the ticker code “SPPHA” Provides investors access to high-quality infrastructure debt NEW YORK... Read more.
Vertical Aerospace Unveils Valo – the eVTOL Aircraft Set to Redefine Urban Air Mobility and Usher in a New Era of Flight
A significantly enhanced design built on the successes of the VX4 prototype test programme A flexible, premium cabin for up to 6 passengers with class-leading luggage... Read more.
KOSA and MegazoneCloud Help 13 Korean AI and Software Firms Expand into Japan
Tokyo Business Meetup with a large Japanese SI corporation, a financial group, and a Major logistics group SIer from November 17 to 19 SEOUL, South Korea–(BUSINESS... Read more.
Cerebras Delivers End-to-End Training and Inference for Jais 2, the World’s Leading Open Arabic LLM
Trained on the industry’s largest, highest-quality Arabic-first dataset, Jais 2 sets new standards for accuracy, fluency, and cultural intelligence SUNNYVALE,... Read more.
CORRECTING and REPLACING First Trust Announces Approval of Liquidation of the First Trust RiverFront Dynamic Europe ETF
WHEATON, Ill.–(BUSINESS WIRE)–In the third and fourth paragraphs of the release all dates should be for January of 2026 (instead of January of 2025).... Read more.
Trecora acquires Deltech Monomers assets in Baton Rouge, LA
THE WOODLANDS, Texas–(BUSINESS WIRE)–Trecora has acquired the assets of Deltech Monomers OpCo LLC, located in Baton Rouge, Louisiana. The acquired facility... Read more.
Oncolytics Biotech® Reschedules Special Meeting of Shareholders to Change Jurisdiction of Incorporation to Nevada
SAN DIEGO–(BUSINESS WIRE)–Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing... Read more.
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated... Read more.
FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Niemann-Pick Disease Type C
Breakthrough Therapy Designation is based on FDA’s review of survival analyses comparing adrabetadex-treated patients with external controls and marks a significant... Read more.
Rivalry Capital Launches as Next-Generation Private Equity Firm Focusing on Healthcare Transformation
DENVER–(BUSINESS WIRE)–Rivalry Capital today announced its official launch, introducing a next-generation private equity firm that combines applied mathematics... Read more.